Table: Torii Pharmaceutical - 6-MTH parent results
Jul 30 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2018 Jun 30, 2017 Dec 31, 2018
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 30.55 30.09 61.50
(+1.5 pct) (+3.7 pct) (-4.1 pct)
Operating 2.11 2.37 3.50
(-11.0 pct) (+7.0 pct) (-44.3 pct)
Recurring 2.16 2.41 3.60
(-10.4 pct) (+5.3 pct) (-43.8 pct)
Net 1.55 1.76 2.60
(-12.0 pct) (+18.7 pct) (-44.9 pct)
EPS 55.22 yen 62.78 yen 92.68 yen
EPS Diluted 55.21 yen
Ann Div 48.00 yen 48.00 yen
-Q2 div 24.00 yen 24.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)